UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinic ...
Others include a partnership between Biogen and Sangamo and Eli Lilly's $1 billion takeover of Prevail in 2020 ... drug developers including Gain Therapeutics, MODAG, and Alterity Therapeutics.
For over 150 years, Bristol-Myers Squibb (BMS) has been committed to "discover, develop and deliver innovative medicines that help patients prevail ... which was a cancer therapeutics company ...
EAU CLAIRE, Wis. (WEAU) - A car crashed into Prevail Bank on Fairfax Street by HyVee Friday evening. Our photojournalist on scene saw the car almost completely in the building with a tow truck pulling ...
Germany’s Merck KGaA is in advanced talks to aquire the U.S. biopharmaceutical company that specializes in rare diseases and cancer.
Dividend stocks can be terrific investments. The best ones provide investors with passive income and upside potential. Over ...
MANILA, Philippines — The shear line and the northeast monsoon will continue to bring cloudy skies and rains to several areas of the country, the weather bureau said Saturday. In its 4 a.m. bulletin, ...
Suntory boss expects to sell less in Europe, Canada and Mexico as a result of US president’s protectionist trade policies ...
Good day, and thank you for standing by. Welcome to the Arm third quarter fiscal year 2025 webcast and conference call. At this time, all participants are in a listen-only mode. After the speakers ...
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025(Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodi ...
Austrian sensor maker ams OSRAM on Tuesday forecast first quarter revenue below or in line with last year's number, citing muted demand for its automotive semiconductors. The company sees revenue ...
Dyne Therapeutics Inc.-5.60% $1.56B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results